Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence

Alexandra Kilian, Marianne S. Clancy, Scott Olitsky, James R. Gossage, Marie E. Faughnan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)53-55
Number of pages3
JournalVascular Medicine (United Kingdom)
Volume26
Issue number1
DOIs
StatePublished - Feb 2021

Keywords

  • arteriovenous malformation
  • cerebral
  • hereditary hemorrhagic telangiectasia (HHT)
  • pulmonary
  • rare diseases
  • screening

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this